Randomized Controlled Trial
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
Ann. Intern. Med. 2011 May 3;154(9):573-82.
Randomized Controlled Trial
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.
J. Allergy Clin. Immunol. 2003 Jan 1;111(1):87-90.
Randomized Controlled Trial
Omalizumab is effective in the long-term control of severe allergic asthma.
Ann. Allergy Asthma Immunol. 2003 Aug 1;91(2):154-9.